GE HEALTHCARE TECHNOLOGIES INC. Share-based Payment Arrangement, Expense, Tax Benefit
GE HEALTHCARE TECHNOLOGIES INC. (GEHC) reported Share-based Payment Arrangement, Expense, Tax Benefit of $24.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-02-04
- GE HEALTHCARE TECHNOLOGIES INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2023-12-31 was $8.00M.
- GE HEALTHCARE TECHNOLOGIES INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2023-09-30 was $4.00M.
- GE HEALTHCARE TECHNOLOGIES INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2023-06-30 was $3.00M.
- GE HEALTHCARE TECHNOLOGIES INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2023-03-31 was $8.00M.
- GE HEALTHCARE TECHNOLOGIES INC. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $24.00M, a 4.35% increase from fiscal 2024.
- GE HEALTHCARE TECHNOLOGIES INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $23.00M, a 0.00% change from fiscal 2023.
- GE HEALTHCARE TECHNOLOGIES INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $23.00M.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|---|---|
| 2025-12-31 | $24.00M 10-K · filed 2026-02-04 | |||
| 2024-12-31 | $23.00M 10-K · filed 2026-02-04 | |||
| 2023-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $12.00M derived: sum of 2 quarters · filed 2026-02-04 | $15.00M derived: sum of 3 quarters · filed 2026-02-04 | $23.00M 10-K · filed 2026-02-04 |
| 2023-09-30 | $4.00M 10-Q · filed 2023-10-31 | $7.00M derived: sum of 2 quarters · filed 2023-10-31 | $15.00M 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $3.00M 10-Q · filed 2023-07-25 | $11.00M 10-Q · filed 2023-07-25 | ||
| 2023-03-31 | $8.00M 10-Q · filed 2023-04-25 |